bisoprolol has been researched along with Hypertension, Malignant in 2 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rubin, S | 1 |
Lacraz, A | 1 |
Galantine, V | 1 |
Gosse, P | 1 |
Tomek, M | 1 |
Nandoskar, A | 1 |
Chapman, N | 1 |
Gabriel, C | 1 |
2 other studies available for bisoprolol and Hypertension, Malignant
Article | Year |
---|---|
Malignant hypertension and interferon-beta: a case report.
Topics: Adult; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Bisoprolol; Female; Humans; Hypertensi | 2014 |
Facial nerve palsy in the setting of malignant hypertension: a link not to be missed.
Topics: Adult; Antihypertensive Agents; Bell Palsy; Bendroflumethiazide; Bisoprolol; Facial Nerve; Facial Pa | 2015 |